publication date: Aug. 8, 2014

html Obit.html

Emmanuel Farber, Experimental Pathologist, Dies at Age 95

Emmanuel Farber, a pathologist who made contributions to the understanding of chemical carcinogenesis, died Sunday, Aug. 3.

Farber’s studies in experimental pathology demonstrated that chemical carcinogens are capable of binding to nucleic acids, in turn generating specific DNA adducts. This led to the observation that chemical carcinogenesis is a sequential process, and he proved this theory by showing that cancer could be induced through a series of step-by-step chemical treatments in the liver, according to an obituary published by the American Association for Cancer Research.

Farber served on the surgeon general’s first Advisory Committee on Smoking and Health from 1961 to 1964. The committee was responsible for issuing the 1964 Surgeon General’s Report on the dangers of smoking and tobacco-related disease.

Farber was born in Toronto Oct. 19, 1918. He received his medical degree from the University of Toronto in 1942. After completing his residency training in pathology at the Hamilton General Hospital, he served in the Royal Canadian Army Medical Corps, and later obtained a doctorate in biochemistry from the University of California, Berkeley.

He was later named professor and chairman of pathology and professor of biochemistry at the University of Pittsburgh School of Medicine and at the Fels Research Institute of Temple University, where he was professor of pathology and biochemistry and director of the institute.

In 1975, Farber returned to Toronto to serve as professor and chairman of the Department of Pathology and professor in the Department of Biochemistry at the University of Toronto. At his death, he held the title of chairman emeritus and professor in the Department of … Continue reading 40-32 Obituary: Emmanuel Farber, Experimental Pathologist, Dies at Age 95

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.